Background Multiple chemical sensitivity (MCS), although poorly understood, is associated with considerable morbidity.
Introduction
Multiple chemical sensitivity (MCS), also known as idiopathic environmental intolerance [1, 2] , has been described as medically unexplained [3] , disabling multi-organ symptoms triggered by multiple incitants with toxicant-induced loss of tolerance to chemicals [1, 4, 5] , somatization disorder [6, 7] , irrational fear of chemicals [8] and panic attacks paired with non-noxious stimuli [9, 10] .
Complex hypotheses have been developed to explain increased sensitivity to environmental exposures including: an immunological mechanism [11, 12] that others dispute [13, 14] ; psychoneuroimmunology linking stress to the down-regulation of the immune system [15] ; neural sensitization with progressive amplification of behavioural and neurochemical host responses [16] ; neurogenic inflammation [17] with the binding of an irritant molecule to sensory nerve C-fibers [18] triggering the release of the inflammatory substance P. Recently, the vomeronasal organ and its possible role in MCS has been described [19] , providing a mechanism for symptoms arising from very low-level exposures and consistent with the altered sense of smell reported by MCS patients [20, 21] .
Environmental exposures to chemicals seem an essential element of MCS. We therefore conducted a case-control study to determine which, if any, serum volatile organic compounds (VOCs) may be increased and which may be decreased [22] in MCS patients compared with people without MCS. We also examined whether MCS is associated with increased serum pesticides or with altered liver function, the latter a possible indicator of impaired enzymatic ability to 'detoxify' chemicals [1, 4, 5] . Additionally, our laboratory protocol for identifying major co-morbidity allowed consideration of other hypothesized mechanisms involved in MCS. Low blood counts could be related to decreased energy or decreased immune function. Abnormal glucose metabolism, including hypoglycaemic episodes, might cause fatigue [23] , as could reduced thyroid function [16, 24] . Vitamin B12 metabolism could be associated with cognitive symptoms [25] , which are a feature of MCS [3, 20] . Vitamin B6 deficiency might explain diminished immune competence, bloating and irritability [26] .
Materials and methods

Development of case-definition
The University of Toronto Health Survey (UTHS) is a reproducible, self-administered questionnaire, designed to assess symptoms, exposures linked to symptoms and specific MCS 'features' described in six previously published MCS case-definitions [4, [27] [28] [29] [30] [31] . The UTHS was sent to 4126 individuals attending four practice types: family medicine, allergy, occupational medicine and environmental medicine; 61.7% responded [32] . Our analysis of UTHS responses revealed that two MCS features described by Nethercott et al. [31] , namely 'symptoms linked to low-level exposure resolving with removal of the exposure' and 'symptom chronicity', differentiated female respondents attending environmental medicine practices (with a high likelihood of MCS) from those attending general practices (with a low likelihood) [20] . Furthermore, combinations of four self-reported UTHS symptoms also discriminated between women from these two practice types. The four symptoms were a stronger sense of smell than others have; feeling dull or groggy; feeling spacey; and difficulty concentrating. To achieve discrimination required either a stronger sense of smell than others or, in the absence of that symptom, any two of the three remaining UTHS symptoms [20] .
Selection of cases and controls
Prior UTHS response was required to enable application of eligibility criteria. Only responders who had volunteered to participate in future research studies were approached. Eligible participants were female Toronto residents, age 30-64 years and not pregnant, attending any participating environmental, allergy, occupational or family practices, the Women's College Hospital (WCH) Environmental Health Clinic (EHC), or the WCH Family Practice Health Center. Cases were required to fulfil both Nethercott features and either of the two discriminatory combinations of UTHS symptoms, as described above [20] . Controls, drawn only from family practices, were ineligible if they reported either of the two Nethercott features or a stronger sense of smell than others or more than one of the other three UTHS symptoms.
Potential cases (493) and controls (481) received invitation letters requesting they notify study investigators if unwilling to participate. Otherwise, recipients were telephoned (eight attempts) and invited to enrol. Ultimately, we recruited 223 cases and 194 controls, a 64 and 50% response, respectively, of those reached and eligible. Forty-six controls reported one UTHS symptom and the remainder none.
Study conduct
Ethical review boards at WCH, an affiliated teaching hospital, and the University approved the protocol. The study proceeded through the autumn and winter of 1997-1998 at the WCH EHC. Participants arrived fasting for morning appointments. Criteria and results for laboratory methods are available as Supplementary data at Occupational Medicine Online.
Analysis
We used descriptive statistics for haematological, C. J. BAINES ET AL.: CASE-CONTROL STUDY OF MULTIPLE CHEMICAL SENSITIVITY 409 biochemical and VOC results. We compared univariate case-control differences in means and proportions using χ 2 and t-tests, with natural log (ln) transformations when required. We used Tobit regression analysis when distribution of the dependent variable was concentrated at the lower limit and when values above that limit covered a wide range. This allowed actual values of the dependent variable to be modelled while accounting for concentration of values at the limit [33] . We calculated the homeostasis model assessment (HOMA) index for insulin resistance [34] .
Sample volumes met the pre-specified instrument detection limits (IDL) for 21 VOCs and one pesticide (see Online table 2). We report results for analytes yielding a case-control difference meeting P < 0.10, namely: chloroform, benzene, ethylbenzene, styrene, 1,3,5-and 1,2,3-trimethylbenzene, 2-and 3-methylpentane, hexane, m&p-xylene and 1,1-dichloro-2,2-bis (p-chlorophenyl) ethylene (p,p′-DDE). We compared 'mean detectable' (MD) statistics, calculated as the mean of values at and above the IDL, for cases and controls with detectable VOC levels. 'Mean of all' (MOA) statistics were averages including VOC levels above, at and below the IDL, the latter treated as IDL equivalent.
Logistic regression estimated dose-response relationships. Based on the control distribution, we divided exposure measures into roughly equal groups. Odds ratios (ORs) revealed the associations between levels of exposure and probability of being a case. When appropriate, multivariate logistic regression [35] controlled for potential confounders [birth in Canada (BIC), vitamin supplement use (VSU) within 24 h of venepuncture, currently smoke daily or most days, age, and coffee, tea and alcohol intake]. Analysis of thyroid stimulating hormone (TSH) results was controlled for thyroid medication use.
Correlation coefficients for combined case-control data evaluated the relationship between liver function tests and analytes listed above.
Results
Cases and controls did not differ significantly with respect to age, marital status, educational background, daily smoking or daily passive smoking, although before logarithmic transformation, they did differ on the mean numbers of cigarettes smoked (Table 1) . Cases were significantly more likely to have been born in Canada and to report VSU. Table 2 , mean cell haemoglobin concentration (MCHC) was higher in cases (P = 0.002) while mean lymphocyte count was lower (P = 0.004), both retaining significance after adjustment for age and smoking (data not shown). Mean values for remaining haematology variables were similar for cases and controls (Online table 3 ), but cases were more likely to fall outside the reference interval for eosinophils (P = 0.03) and neutrophils (P = 0.02) (data not shown). Mean alanine-aminotransferase (ALT) was higher in cases (P = 0.007) ( Table 2) , even after adjustment (data not shown) for vitamin B6 levels (P = 0.01). While cases and controls differed on alcohol intake, ALT was not associated with alcohol nor with tea and coffee. Mean TSH, creatinine, fasting blood glucose and serum insulin levels, the HOMA index and gamma glutamyl transpeptidase (GGTP) were almost identical, comparing cases and controls (Online table 4). Adjusting for age and smoking had no effect (data not shown). Table 3 shows that higher levels of vitamins B12 and B6 were observed in cases even after stratification, with the differences significant for all strata combined both crude and adjusted for VSU. In contrast, the higher levels of folate seen in cases compared with controls were not observed after VSU stratification, although adjustment for VSU did yield a statistically significant difference. Plasma homocysteine was lower for cases than controls among users of vitamin supplements, but not among non-users. Adjustment for VSU showed a non-significant difference at the P = 0.08 level. Neither removal of outliers nor adjustment for smoking and age changed these findings (data not shown). Table 4 shows dose-response relationships which are not always monotonic. Higher MCHC and lower erythrocyte and lymphocyte counts were significantly associated with an increased probability of being a case. Crude and adjusted ORs show that ALT levels above quartile 1 were associated with an increased risk of being a case. However, no dose-response relationship was observed for other biochemistry variables. Dose-response relationships are also displayed in Table 4 for vitamin B12, folate, total homocysteine and vitamin B6. After adjustment, only higher vitamin B6 was associated with an increased likelihood of being a case (P = 0.02), while higher homocysteine was associated with reduced risk (P = 0.10).
Routine laboratory results
As shown in
Volatile organic compounds
First, with respect to detectability, higher proportions of cases (Table 5 ) had detectable levels of chloroform (OR = 2.78, P < 0.001) and benzene (OR = 1.48, P = 0.06). Significantly lower proportions of cases had detectable levels of 1,3,5-trimethylbenzene (P = 0.04), 2-methylpentane (P = 0.007), 1,2,3-trimethylbenzene (P = 0.01), 3-methylpentane (P = 0.03) and hexane (P = 0.02). One hundred per cent p,p′-DDE detectability occurred in cases and controls. None of the other pesticides tested for were detectable. Secondly, with respect to mean VOC levels, chloroform levels were higher in cases than controls, significantly for MOA. Levels of p,p′-DDE were similar in cases and controls. For all other VOCs, levels were consistently lower in cases with varying degrees of significance whether expressed as MD or MOA levels. MOA levels were significantly lower in cases for 1,3,5-trimethylbenzene (P = 0.02), 2-methylpentane (P = 0.02), 1,2,3-trimethylbenzene (P = 0.01), 3-methylpentane (P = 0.002), hexane (P < 0.001) and m&p-xylene (P = 0.01).
In terms of dose-response relationships, Table 6 shows that, compared with the lowest quartile, chloroform levels in quartiles 2 or higher approximately doubled the risk of being a case. Ethylbenzene, 3-methylpentane, hexane, m&p-xylene and 1,2,3-trimethylbenzene levels were negatively associated with varying degrees of significance.
Only m&p-xylene and 1,2,3-trimethylbenzene exhibited a monotonic dose-response relationship. No associations were found between ALT and any of the VOCs listed in Table 5 . GGTP was negatively associated with ethylbenzene (beta = -0.19, P = 0.02) and 1,2,3-trimethylbenzene (beta = -0.33, P = 0.02). (Online table  5 shows associations involving other VOCs and GGTP.)
Discussion
We believe this study using MCS cases and controls meeting validated exclusion and inclusion criteria is unique [20] . Others based a case definition on symptom-causing exposures [36] . By basing our case definition on symptoms, we avoided the risk of incorrectly attributing symptoms to specific exposures. Our case definition is a major strength of this paper. Nevertheless, our case-control differences require replication to avoid problems of multiple significance testing. The potential for confounding exists, particularly with respect to behaviour, diet and social factors for which data were not collected. However, our analysis adjusted for potential confounding by BIC, alcohol, coffee, tea and smoking. The relatively low compliance rate in agreeing to participate in this study precludes generalizing our findings to all MCS cases. Bias could arise in our case-control comparisons if there were self-selection bias involving exposures which differed between cases and controls. We do not believe the decision to participate was influenced by MCS-related variables.
Our statistically significant (although clinically unimportant) case-control differences deserve attention given the potential relevance to some proposed biological mechanisms for MCS.
Routine laboratory results
We ruled out serious co-morbidity from anaemia, liver disease, diabetes, kidney disease and hypothyroidism. There were no exclusions because of medical conditions. MCHC case-control differences persisted (P = 0.001) after adjustment for ALT, B12, TSH, folate, alcohol and smoking, all variables associated with megaloblastic anaemia, which is itself associated with elevated MCHC (data not shown) [37] . Although the difference in means was very small, the more than double increased risk of being a case was confined to those in the upper quartile. Whether this reflects biology or chance requires further investigation in the context of social and dietary factors.
Although the lower mean lymphocyte count in cases (P = 0.004) was clinically unimportant, these lower counts were associated with an increased likelihood of case status even after adjustment. The relative lymphocytopenia and negative dose-response relationship observed in cases is consistent with speculation that there is down-regulation of the immune system in MCS [15] .
Eosinophils synthesize, store and secrete nerve growth factor [38] . Although the higher mean count in cases was not statistically significant, significantly more cases had eosinophil counts higher than the reference interval, consistent with the neurogenic inflammation hypothesis [17] . However, small numbers (21 versus 9) rule out anything other than a minor potential role in explaining MCS.
Abnormal glucose metabolism, including hypoglycaemic episodes, could cause fatigue in MCS [23] , but our findings support neither this nor the possibility that MCS cases have reduced thyroid function [16, 24] as determined by TSH.
Vitamin B12 metabolism was investigated because of its association with neurological symptoms [25] . Because B12 serum levels may not reflect tissue supply, we measured total plasma homocysteine, an indicator of vitamin B12 tissue deficiency [39] and serum folate which, when low, may mask B12 deficiency. Mean homocysteine levels were in the middle of the reference interval in both cases and controls. Thus, mean B12 tissue levels were probably adequate in cases and controls [40] . Folate levels were high in both cases and controls, possibly due to folate food fortification in Ontario [41] . Our results do not support the hypothesis that impaired vitamin B12 metabolism contributes to neurobehavioural and cognitive dysfunction in MCS.
In focus groups conducted prior to study implementation, some clinicians reported low serum B6 levels in~60% of MCS patients. However, we report a higher mean vitamin B6 level in cases with a significant linear dose-response relationship, even after adjustment. Our findings support neither the clinical observations nor the hypothesis that B6 deficiency is linked to diminished immune competence in MCS [26] .
Volatile organic compounds
Environmental analyses routinely use the conservative method detection limit (MDL) as a reporting limit. In contrast, clinical laboratories in the USA that provide VOC scans to North American physicians treating MCS patients use IDLs. By using IDLs, we enabled these clinicians to make direct comparisons of our VOC levels with their clinical experience. Additionally, IDLs captured more measurements than MDLs for analysis.
Some case-control differences may be masked because we recruited prevalent cases who might have modified their behaviour to avoid exposures causing symptoms. Incident cases could not be recruited because the recognition of MCS is generally retrospective.
Increased susceptibility to adverse effects from environmental chemicals due to an impaired enzymatic ability to detoxify 'intoxicants' has been hypothesized for MCS. Either increased or decreased serum VOC levels could be relevant indicators [1] . Rapid metabolizers may have lower levels of a compound and experience toxicity from a reactive intermediate, while slow metabolizers may have increased levels and experience toxicity from the parent compound [22] . Our results are consistent with these hypotheses; we showed increases in some VOCs and decreases in others. The three chloroform measures were higher in cases, significantly so for the proportion with detectable levels and the MOA. Airborne contamination during venepuncture or sample preparation was unlikely because samples were handled identically. Laboratory blanks were not contaminated. Chloroform exposure could arise from drinking chlorinated tap water or inhaling chlorinated water vapour during showers [42, 43] . We did not collect information on water use. Other possible explanations are impaired detoxification or excretion of chloroform, or increased absorption and/or storage. Chloroform was not correlated with liver function tests. Given chloroform's anaesthetic properties, its relationship with MCSassociated cognitive symptoms warrants investigation.
Lower proportions of cases had detectable levels for eight of eleven analytes. Except for chloroform and p,p′-DDE, cases also had lower MD and MOA levels. Excluding chloroform, styrene and p,p′-DDE, the VOCs listed in Table 5 are gasoline constituents [44] . Mainstream cigarette smoke contains benzene, ethylbenzene, styrene and m&p-xylene [43] , the latter three showing significantly lower means in cases. Possible explanations for lower levels in cases include avoidance of exposure to vehicular exhaust and passive smoking, more rapid VOC breakdown or enhanced tissue storage.
For 2-methyl pentane, both the MOA and the proportion with detectable levels were significantly lower in cases. 2-Methyl pentane is primarily exhaled. If cases hyperventilate more than controls [9] , it could explain lower levels.
Styrene is in indoor air and occurs in food both naturally and after storage in polystyrene containers [45] . The MD styrene level was lower in cases than controls.
Similar p,p′-DDE levels in cases and controls suggest similar exposure and metabolic pathways. Levels of all other pesticides were undetectable in cases and controls.
Because liver function and VOC metabolism were possible related, we measured ALT, a marker for hepatocellular injury which is decreased in vitamin B6 deficiency and increased by some drugs and liver disease [37] . The significantly higher mean ALT level in cases, even after adjusting for vitamin B6 and VSU, and the significant but not monotonic dose-response relationship might indicate increased enzyme induction in cases and represent slightly impaired detoxification, consistent with MCS being a toxicant-induced condition [1, 5] . GGTP, a microsomal enzyme increased by drugs, alcohol, xenobiotics, infection and cancer, reflects liver function [37, 46] . The absence of a GGTP case-control difference suggests similar exposures and morbidity for these variables.
Conclusions
This study identified case-control differences for MCHC, lymphocytes, vitamin B6 and homocysteine. Of great interest are the VOC measurements, particularly the increased likelihood of chloroform detectability (OR = 2.78, P < 0.001) and the higher chloroform levels in cases. Replication is required.
Dose-response relationships are a major criterion for establishing causality and several were shown. The lymphocyte count demonstrated a strictly monotonic relationship, with higher counts reducing the risk of being a case. For VOCs, the likelihood of being a case doubled in quartiles 2-4 for chloroform. In contrast, the likelihood of being a case was lower in quartiles above 1 for ethylbenzene, 3-methyl pentane, hexane, m&p-xylene and 1,2,3-trimethylbenzene. Only for the latter two is the relationship monotonic.
Research is required to confirm our results and clarify underlying mechanisms in MCS. What metabolic pathways are involved and how do they differ between cases and controls?
